Fiercepharma
Published September 9, 2026 · Updated September 10, 2026
FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits
Read the full story at Fiercepharma
A psychiatrist and pharmacologist by training, he was also formerly the chief medical officer at non-profit psychedelic drug developer Usona Institute.
Surfaced by this Google Alert
- Psychedelic biotech
